NP / PA
Summits Healthcare, LLC
Summits Healthcare, LLC was paid $2.19M by Medicaid between Mar 2020 and Dec 2024, across 21 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 37% of everything it billed.
33Billing provider infoSUMMITS HEALTHCARE, LLC
DEMING, NM 88030
DEMING, NM 88030
33aNPI1740833243assigned 07/23/2019
33bProvider typeFamily Nurse Practitioner
28Total paid$2.19M
24GClaims32,730
24DCodes billed21
24AFirst – last monthMar 2020 – Dec 2024
Compared with peers
Next to other Family Nurse Practitioner providers in New Mexico
Rank by total paid#6 of 73
Median peer was paid$90K
This provider vs. median24×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 1,259 | $81K | |
| 2021 | 10,786 | $671K | |
| 2022 | 8,651 | $574K | |
| 2023 | 5,868 | $401K | |
| 2024incomplete | 6,166 | $462K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 37% | 8,399 | 7,282 | $812K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21% | 6,188 | 5,540 | $452K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 15% | 6,331 | 5,709 | $324K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 9.5% | 2,115 | 2,106 | $209K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 6.9% | 1,001 | 993 | $152K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 3.2% | 1,796 | 1,724 | $70K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 2.8% | 934 | 929 | $61K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.9% | 2,349 | 1,150 | $41K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.2% | 1,506 | 1,477 | $26K |
| 0012A | <1% | 283 | 283 | $11K | |
| 0011A | <1% | 289 | 289 | $11K | |
| M0240 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses | <1% | 21 | 21 | $9K |
9 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 166 | $8K |
| 93000 | <1% | 83 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 44 | $778.18 |
| 81003 | <1% | 513 | $627.42 | |
| 87807 | <1% | 45 | $534.88 | |
| 81025 | <1% | 29 | $299.01 | |
| 90688 | <1% | 13 | $142.46 | |
| 91301 | <1% | 605 | $3.75 | |
| Q0240 | Injection, casirivimab and imdevimab, 600 mg | <1% | 20 | $0.12 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHANDER, EDUARD (OWNER/PROVIDER)